Bör regeringen reglera priserna på livräddande läkemedel?
Ja, och regeringen bör reglera priset på alla receptbelagda läkemedel
We have to find a healthy balance between grotesque oversight that hinders our research and development and cripples incentive, and Corporate greed that hurts its customers/patients to the degree of not only attacking the current healthcare system but hurts the outlook of their own product. Collateral damage must be acknowledged and addressed by both sides of the docket. Punitive measures have always stalled progress while incentives have at least proven a percentage of success for all. We should chase for a more perfect incentive system as if it were written in the preamble itself!
Var först med att svara på denna oenighet .